Latest Biostrophin Stories
View: MDA-AVI BioPharma-YouTube for Mon. 8-15-11 (http://www.youtube.com/watch?v=4pR4a24MHvk ) View: MDA-AVI BioPharma-YouTube for Tues. 8-16-11 (http://www.youtube.com/watch?v=S3aaBZ0az4E) View: MDA-AVI BioPharma-High Res. for Mon. 8-15-11 View: MDA-AVI BioPharma-High Res. for Tues.
Grant Funds Work of Ronald G. Victor, M.D.
AMSTERDAM, March 7, 2011 /PRNewswire-FirstCall/ -- Amsterdam Molecular Therapeutics (AMT) (Euronext: AMT), a leader in the field of human gene therapy, announced today that the Duchenne Parent Project, based in the Netherlands, has awarded AMT a grant of EUR 145,000 to support the development of AMT-080, AMT's gene therapy for Duchenne Muscular Dystrophy (DMD).
Efforts over decade result in $192 million in Duchenne-specific federal investment HACKENSACK, N.J., Feb.
SOUTH PLAINFIELD, N.J. and HACKENSACK, N.J., Feb. 1, 2011 /PRNewswire/ -- PTC Therapeutics, Inc. (PTC) and Parent Project Muscular Dystrophy (PPMD) today announced an expansion of their collaboration to discover new treatments for patients with Duchenne/Becker muscular dystrophy (DBMD).
HACKENSACK, N.J., Nov.
SOUTH PLAINFIELD, N.J., Oct. 15 /PRNewswire/ -- PTC Therapeutics, Inc.
Dr. Jerry Mendell Leading Follistatin Gene Therapy MIDDLETOWN, Ohio, Aug.